Work

Phase 1/1b trial of fruquintinib in patients with advanced solid tumors: Preliminary results of the dose expansion cohorts in refractory metastatic colorectal cancer.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.4_suppl.093

Authors: Arvind Dasari, Joleen M. Hubbard, Cathy Eng, Heather Yeckes-Rodin, Stacey M Ukrainskyj, Zhao Yang, William R. Schelman, Marek K. Kania, Tanios S. Bekaii-Saab

Institutions: The University of Texas MD Anderson Cancer Center, Mayo Clinic, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Cleveland Clinic Florida, HUTCHMED (China) Limited (China), Mayo Clinic Hospital

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4205145932

Cites:

Cited by: 1

Related to: 10